Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Jürg Bernhard; Weixiu Luo; Karin Ribi; Marco Colleoni; Harold J Burstein; Carlo Tondini; Graziella Pinotti; Simon Spazzapan; Thomas Ruhstaller; Fabio Puglisi; Lorenzo Pavesi; Vani Parmar; Meredith M Regan; Olivia Pagani; Gini F Fleming; Prudence A Francis; Karen N Price; Alan S Coates; Richard D Gelber; Aron Goldhirsch; Barbara A Walley

doi:10.1016/S1470-2045(15)00049-2

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Jürg Bernhard
, Weixiu Luo
, Karin Ribi
, Marco Colleoni
, Harold J Burstein
, Carlo Tondini
, Graziella Pinotti
, Simon Spazzapan
, Thomas Ruhstaller
, Fabio Puglisi
, Lorenzo Pavesi
, Vani Parmar
, Meredith M Regan
, Olivia Pagani
, Gini F Fleming
, Prudence A Francis
, Karen N Price
, Alan S Coates
, Richard D Gelber
, Aron Goldhirsch

Barbara A Walley

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	848-858
Journal	The Lancet Oncology
Volume	16
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(15)00049-2
Publication status	Published - 1 Jul 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1470-2045(15)00049-2

https://linkinghub.elsevier.com/retrieve/pii/S1470204515000492

Cite this

Bernhard, J., Luo, W., Ribi, K., Colleoni, M., Burstein, H. J., Tondini, C., Pinotti, G., Spazzapan, S., Ruhstaller, T., Puglisi, F., Pavesi, L., Parmar, V., Regan, M. M., Pagani, O., Fleming, G. F., Francis, P. A., Price, K. N., Coates, A. S., Gelber, R. D., ... Walley, B. A. (2015). Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. The Lancet Oncology, 16(7), 848-858. https://doi.org/10.1016/S1470-2045(15)00049-2

@article{795d8bf02d364f0d87e7afc2198c05ca,

title = "Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials",

author = "J{\"u}rg Bernhard and Weixiu Luo and Karin Ribi and Marco Colleoni and Burstein, \{Harold J\} and Carlo Tondini and Graziella Pinotti and Simon Spazzapan and Thomas Ruhstaller and Fabio Puglisi and Lorenzo Pavesi and Vani Parmar and Regan, \{Meredith M\} and Olivia Pagani and Fleming, \{Gini F\} and Francis, \{Prudence A\} and Price, \{Karen N\} and Coates, \{Alan S\} and Gelber, \{Richard D\} and Aron Goldhirsch and Walley, \{Barbara A\}",

year = "2015",

month = jul,

day = "1",

doi = "10.1016/S1470-2045(15)00049-2",

language = "English",

volume = "16",

pages = "848--858",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "7",

}

Bernhard, J, Luo, W, Ribi, K, Colleoni, M, Burstein, HJ, Tondini, C, Pinotti, G, Spazzapan, S, Ruhstaller, T, Puglisi, F, Pavesi, L, Parmar, V, Regan, MM, Pagani, O, Fleming, GF, Francis, PA, Price, KN, Coates, AS, Gelber, RD, Goldhirsch, A & Walley, BA 2015, 'Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials', The Lancet Oncology, vol. 16, no. 7, pp. 848-858. https://doi.org/10.1016/S1470-2045(15)00049-2

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. / Bernhard, Jürg; Luo, Weixiu; Ribi, Karin et al.
In: The Lancet Oncology, Vol. 16, No. 7, 01.07.2015, p. 848-858.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

AU - Bernhard, Jürg

AU - Luo, Weixiu

AU - Ribi, Karin

AU - Colleoni, Marco

AU - Burstein, Harold J

AU - Tondini, Carlo

AU - Pinotti, Graziella

AU - Spazzapan, Simon

AU - Ruhstaller, Thomas

AU - Puglisi, Fabio

AU - Pavesi, Lorenzo

AU - Parmar, Vani

AU - Regan, Meredith M

AU - Pagani, Olivia

AU - Fleming, Gini F

AU - Francis, Prudence A

AU - Price, Karen N

AU - Coates, Alan S

AU - Gelber, Richard D

AU - Goldhirsch, Aron

AU - Walley, Barbara A

PY - 2015/7/1

Y1 - 2015/7/1

U2 - 10.1016/S1470-2045(15)00049-2

DO - 10.1016/S1470-2045(15)00049-2

M3 - Article

SN - 1470-2045

VL - 16

SP - 848

EP - 858

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 7

ER -